Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: There is limited information from large-scale prospective studies regarding the prediction of type 1 diabetes by specific types of pancreatic islet autoantibodies, either alone or in combination. Thus, we studied the extent to which specific autoantibodies are predictive of type 1 diabetes. RESEARCH DESIGN AND METHODS: Two cohorts were derived from the first screening for islet cell autoantibodies (ICAs) in the Diabetes Prevention Trial-Type 1 (DPT-1). Autoantibodies to GAD 65 (GAD65), insulinoma-associated antigen-2 (ICA512), and insulin (micro-IAA [mIAA]) were also measured. Participants were followed for the occurrence of type 1 diabetes. One cohort (Questionnaire) included those who did not enter the DPT-1 trials, but responded to questionnaires (n = 28,507, 2.4% ICA(+)). The other cohort (Trials) included DPT-1 participants (n = 528, 83.3% ICA(+)). RESULTS: In both cohorts autoantibody number was highly predictive of type 1 diabetes (P < 0.001). The Questionnaire cohort was used to assess prediction according to the type of autoantibody. As single autoantibodies, ICA (3.9%), GAD65 (4.4%), and ICA512 (4.6%) were similarly predictive of type 1 diabetes in proportional hazards models (P < 0.001 for all). However, no subjects with mIAA as single autoantibodies developed type 1 diabetes. As second autoantibodies, all except mIAA added significantly (P < 0.001) to the prediction of type 1 diabetes. Within the positive range, GAD65 and ICA autoantibody titers were predictive of type 1 diabetes. CONCLUSIONS: The data indicate that the number of autoantibodies is predictive of type 1 diabetes. However, mIAA is less predictive of type 1 diabetes than other autoantibodies. Autoantibody number, type of autoantibody, and autoantibody titer must be carefully considered in planning prevention trials for type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, the risk of type 1 diabetes increases as the number of relevant autoantibodies detected increases (55,74,75).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, the risk of type 1 diabetes increases as the number of relevant autoantibodies detected increases (53,74,75).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,289
ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIES
Bottazzo, G., Florin-Christensen, A., & Doniach, D. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90140-8 · Cited by 1,469 · cited 2×
“The number shown for each curve (1, 2) indicates the number of autoantibodies.”
BackgroundInsulin antibodies in insulin-dependent diabetics before insulin treatment
Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K., & Paquette, T. L. (1983) · Science · doi:10.1126/science.6362005 · Cited by 1,078
Self-citationEffects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Termination of Pregnancy on Psychiatric Grounds
(1964) · The Lancet · doi:10.1016/s0140-6736(64)92746-1 · Cited by 681
Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes
The Diabetes Prevention Trial-Type 1 Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1068 · Cited by 668
Keele, G. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91022-2 · Cited by 499
EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS
Gorsuch, A. N., Lister, J., Dean, B. M., Spencer, K. M., Mcnally, J. M., Bottazzo, G. F., & Cudworth, A. G. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92795-1 · Cited by 480
Grubin, C. E., Daniels, T., Toivola, B., Landin-Olsson, M., Hagopian, W. A., Li, L., Karlsen, A. E., Boel, E., Michelsen, B., & Lernmark, �. (1994) · Diabetologia · doi:10.1007/bf00408469 · Cited by 415 · cited 1×
“Labeled recombinant GAD65 and ICA512 autoantibodies were produced by in vitro transcription/ translation with differential labeling ([(3)H]GAD65 and [(35)S]ICA512) (8,13).”
MethodBingley, P. J., Christie, M. R., Bonifacio, E., Bonfanti, R., Shattock, M., Fonte, M.-T., Bottazzo, G.-F., & Gale, E. A. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1304 · Cited by 389
Baekkeskov, S., Landin, M., Kristensen, J. K., Srikanta, S., Bruining, G. J., Mandrup-Poulsen, T., de Beaufort, C., Soeldner, J. S., Eisenbarth, G., & Lindgren, F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112903 · Cited by 314
Self-citationKulmala, P., Savola, K., Petersen, J. S., Vähäsalo, P., Karjalainen, J., Löppönen, T., Dyrberg, T., Akerblom, H. K., & Knip, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119879 · Cited by 287
Stratification of Type 1 Diabetes Risk on the Basis of Islet Autoantibody Characteristics
Achenbach, P., Warncke, K., Reiter, J., Naserke, H. E., Williams, A. J. K., Bingley, P. J., Bonifacio, E., & Ziegler, A.-G. (2004) · Diabetes · doi:10.2337/diabetes.53.2.384 · Cited by 280
Payton, M. A., Hawkes, C. J., & Christie, M. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118188 · Cited by 267 · cited 1×
“Labeled recombinant GAD65 and ICA512 autoantibodies were produced by in vitro transcription/ translation with differential labeling ([(3)H]GAD65 and [(35)S]ICA512) (8,13).”
MethodAchenbach, P., Koczwara, K., Knopff, A., Naserke, H., Ziegler, A.-G., & Bonifacio, E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421307 · Cited by 239 · cited 1×
“Thus, it is possible that a sizable proportion of mIAA values represents false-positive results or low-affinity IAA associated with lower risk (26).”
BackgroundA Novel Micro-assay for Insulin Autoantibodies
Williams, A. J. K., Bingley, P. J., Bonifacio, E., Palmer, J. P., & Gale, E. A. M. (1997) · Journal of Autoimmunity · doi:10.1006/jaut.1997.0154 · Cited by 238
Self-citationAntiislet autoantibodies usually develop sequentially rather than simultaneously
Yu, L. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.12.4264 · Cited by 214 · cited 1×
“As described previously, a combined GAD65 and ICA512 radioassay was performed (19).”
BackgroundSelf-citationISLET-CELL ANTIBODIES IN DIABETES MELLITUS
LENDRUM, R. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92033-x · Cited by 210
Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk
Achenbach, P., Lampasona, V., Landherr, U., Koczwara, K., Krause, S., Grallert, H., Winkler, C., Pflüger, M., Illig, T., Bonifacio, E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1438-0 · Cited by 199 · cited 1×
“An autoantibody to zinc transporter 8 has recently been found to be predictive of type 1 diabetes in children (12).”
BackgroundVerge, C. F., Gianani, R., Kawasaki, E., Yu, L., Pietropaolo, M., Chase, P., & Eisenbarth, G. S. (1996) · Journal of Autoimmunity · doi:10.1006/jaut.1996.0051 · Cited by 152 · cited 1×
“The finding that autoantibody number predicts type 1 diabetes is consistent with other studies (9,15).”
ResultSelf-citationBottazzo, G. F., & Gleichmann, H. (1986) · Diabetologia · doi:10.1007/bf00456124 · Cited by 143 · cited 1×
“In the 1995 Immunology of Diabetes Society workshop (18), this ICA assay had a specificity of 100% and a sensitivity of 74.”
BackgroundVALUE OF INSULIN AUTOANTIBODIES AS SERUM MARKERS FOR INSULIN-DEPENDENT DIABETES MELLITUS
Wilkin, T. J., Armitage, M., Casey, C. R., Pyke, D. A., Hoskins, P. J., Rodier, M., Diaz, J.-L., & Leslie, R. D. G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92086-0 · Cited by 141
The European Nicotinamide Diabetes Intervention Trial (ENDIT) Group, Bingley, P. J., & Gale, E. A. M. (2006) · Diabetologia · doi:10.1007/s00125-006-0160-4 · Cited by 124
Krischer, J. P., Cuthbertson, D. D., Yu, L., Orban, T., Maclaren, N., Jackson, R., Winter, W. E., Schatz, D. A., Palmer, J. P., & Eisenbarth, G. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020760 · Cited by 119
Self-citationChristie, M. R., Vohra, G., Champagne, P. S., Daneman, D., & Delovitch, T. L. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.3.789 · Cited by 112
Greenbaum, C. J., Sears, K. L., Kahn, S. E., & Palmer, J. P. (1999) · Diabetes · doi:10.2337/diabetes.48.1.170 · Cited by 84 · cited 1×
“The lack of a mIAA effect was similar to a previous finding of little effect when IAA was included as a third autoantibody (21).”
ResultSelf-citationAutoantibodies to IA-2β improve diabetes risk assessment in high-risk relatives
Achenbach, P., Bonifacio, E. E., Williams, A. J. K., Ziegler, A., Gale, E. A. M., Bingley, P. J., & ENDIT Group (2008) · Diabetologia · doi:10.1007/s00125-007-0912-9 · Cited by 48 · cited 1×
“ICA individuals who were also IA-2 A have been observed to have a high risk for type 1 diabetes (11).”
BackgroundPietropaolo, M., Yu, S., Libman, I. M., Pietropaolo, S. L., Riley, K., LaPorte, R. E., DRASH, A. L., Mazumdar, S., Trucco, M., & BECKER, D. J. (2005) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2005.00127.x · Cited by 47
Bingley, P. J., & Gale, E. (2006) · Cited by 18
Islet cell autoantibodies: a case of a premature obituary
Schatz, D., & Atkinson, M. A. (2005) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2005.00128.x · Cited by 8
Self-citation
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
Metadata
- Authors
- Orban, T., Sosenko, J. M., Cuthbertson, D., Krischer, J. P., Skyler, J. S., Jackson, R., Yu, L., Palmer, J. P., Schatz, D., Eisenbarth, G., & for the Diabetes Prevention Trial–Type 1 Study Group
- Affiliations
- Joslin Diabetes Center (US)
- University of Miami (US)
- University of South Florida (US)
- Barbara Davis Center for Childhood Diabetes, Denver, Colorado;
- University of Washington (US)
- University of Florida Health (US)
- Corresponding author
- Sosenko, Jay M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-09-09
- Volume
- 32
- Issue
- 12
- Pages
- 2269-2274
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2782989
- OpenAlex
- W2164736991
- Cited by
- 260
- References
- 31
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 9 · 2023: 8 · 2022: 18 · 2021: 17 · 2020: 9 · 2019: 18 · 2018: 11 · 2017: 14 · 2016: 20 · 2015: 26 · 2014: 24 · 2013: 24 · 2012: 25
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Joslin Diabetes Center
- National Institute of Diabetes and Digestive and Kidney Diseases (UC4DK117009)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 1 diabetes, islet autoantibodies, GAD65 antibodies, autoantibody titers, diabetes prediction, prevention trials
- MeSH terms
- Autoantibodies, Diabetes Mellitus, Type 1, Glutamate Decarboxylase, Humans, Islets of Langerhans, Predictive Value of Tests, Prospective Studies, Surveys and Questionnaires, Cohort Studies, Receptor-Like Protein Tyrosine Phosphatases, Class 8
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.